Abstract: Introduction: Human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) has been believed not circulate in Indonesia yet. This study evaluated the prevalence of HTLV-1 and 2 in drug abused prisoners imprisoned in correctional facilities in Central of Java Indonesia, to track the presentation of HTLV-1/2 in Indonesia. Methods: A cross-sectional study was conducted in two prisons (Kedung Pane Male Prison Semarang and Women Prison Semarang) in Central of Java Indonesia between August 2009 and October 2009. All drug abused prisoners in both prisons were enrolled in this study (n = 148). Questionnaires were retrieved and bloods were tested in the period using enzyme linked immuno sorbent assays. The serological positive results were then confirmed by RT-PCR nested addressed the part of HTLV-1 LTR and HTLV-2 LTR region, respectively. Results: The average seroprevalence in the period was 1.4% (2/148). All positive serological samples were confirmed by nested RT-PCR. Of these, one was HTLV-1 positive and one was HTLV-2 positive. Molecular analysis of positive PCR products revealed that the HTLV-1 isolate had close relationship with HTLV-1 isolated in Japan while the HTLV-2 isolate with that of isolated in USA. Conclusions: HTLV-1 and HTLV-2 were detected in drug abused prisoners imprisoned in correctional facilities in Central of Java Indonesia indicated that these viruses were circulated in Indonesia.
Introduction


Human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) were the first human retroviruses to be discovered. HTLV-1 is associated with adult T-cell leukemia (ATL), HTLV-associated myelopathy/ tropical spastic paraparesis (HAM/TSP), and HTLV associated uveitis (HAU) [1] . Phylogenetic studies suggest that HTLV-1 arrived in South America through fairly recent, multiple introductions, probably during African slavery. All South American countries have the Pacific basin, and in the aboriginal population in Australia. The seroprevalence of HTLV-1 varies from 0.1% to 30% within endemic populations. Sporadic HTLV-1 infection occurs among at-risk groups from non endemic regions, including metropolitan areas in the United States and western European countries [2] . No molecular epidemiology data of HTLV-1/2 based on correctional facilities have ever been published, for the best of our knowledge.
Little is known about HTLV-1/2 infections in Indonesia especially in drug abused prisoners in correctional facilities. The seroprevalence of HTLV in the healthy blood donors in Jakarta area, which was also reflected in the western part of Indonesia, was very low; however, there was no evidence of the presentation of the viruses. No seropositive individuals were found in healthy Irian Jaya people [3, 4] . However, there is no data about the presentation of HTLV-1/2 in the high risk communities in Indonesia, including the injecting drug users, people with sexual commercial activities, etc. Drug abused prisoners is usually associated with the high risk activities and they will be released into the general community after they finish their punishment, therefore, it is important to screening the presentation of infectious agent like HTLV-1/2 in the prisoners. Thus, the present study aimed to add information concerning HTLV-1/2 in drug abused prisoners imprisoned in correctional facilities in Central of Java Indonesia. We searched for the presence of HTLV-1-and HTLV-2-specific antibodies followed by molecular detection to detect the presentation of the viruses, and tried to role out the risk factor related with HTLV-1/2 infection in the prisoners.
Materials and Methods
Study Population
We conducted a cross-sectional study in two prisons (Kedung Pane Semarang and Women Prison Semarang) in Central of Java Indonesia between August 2009 and October 2009. These facilities serve as the incarceration venue for adult with illicit drug allegations, as well as for adult accused of many other crimes. A list of the drug abused prisoners was obtained from the staff of the correctional facilities, and all of these individuals were recruited (n = 148). All subjects were informed that the study was voluntary and that there would be no negative consequences for refusal. Prisoners had full authority to accept or refuse to take part in the study. Only after the written consent was signed (all prisoners could sign their names), the questionnaire was administered by the interviewer. Approval was obtained from the institutional ethical committee review boards of the Faculty of Medicine of Sebelas Maret University and DR. Moewardi General Hospital Surakarta Indonesia.
Data Collection
Data were collected at the time of blood drawing by questionnaires prepared by the investigator in order to determine socio-demographic characteristics and risk factors related to blood borne virus infection. A face to face verbal interview was conducted in a private room with a trained interviewer. Staff from the correctional facilities did not participate in the study and were not present in the room during the interviews. The questionnaire was administered anonymously and confidentially. After each interview, participants were asked to provide blood samples.
Questionnaires included questions on socio-demographic characteristics, travel, incarceration and medical histories, drug use and sexual behaviors, especially that of related to risk factors for HTLV-1/2 infection. Other transmission routes were also assessed, such as receipt of therapeutic injections.
Serological Assay
A 5 ml blood sample was collected from willing participants and then fractionated, aliquoted, and stocked in -80°C until further study. Specimens were tested at Biomedical Laboratory Faculty of Medicine
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Sebelas Maret University Surakarta Indonesia, analyzed for the presence of specific antibodies to HTLV-1/2 using an ELISA kit that employs HTLV-1/2 viral lysates plus recombinant proteins from HTLV-1/2 as antigens (HTLV-I/II ELISA 4.0, MP Diagnostics, Durhan, DC). The reactions were conducted according to manufacturer instructions.
Molecular Biology Approaches to Confirm HTLV-1 and -2 Infections
Samples who presented reactive or indetermined results on ELISA assay were confirmed by molecular assay. The peripheral mononuclear blood cells (PBMC) were used for nucleic acid extraction and reverse transcriptase polymerase chain reaction (RT-PCR). LTR segments of HTLV-1 and HTLV-2 were amplified to confirm HTLV-1 and HTLV-2 infection, as previously described. Briefly, the segment of LTR regions of the HTLV-1 genome was amplified using primers LTR1/LTR3 in the first round and LTR1/LTR2 in the second round while the segment of LTR regions of the HTLV-2 genome was amplified using primers VS1/VS2 in the first round and VS3/VS4 in the second round [5] .
Determination of Nucleotide Sequences and Phylogenetic Analysis
The PCR products were subjected to the determination of nucleotide sequences directly with the primers of LTR1/LTR2 for HTLV-1 LTR region and VS3/VS4 for HTLV-2 region, respectively. Sequences were then submitted to the BLAST program in order to check their similarity to related strains deposited in Genbank/EMBL/DDBJ. The reference strain with the highest homology score to each analyzed strain was retrieved from the GenBank/EMBL/DDJB database and then was aligned with the tested sequences by ClustalW [6] . The frequency of nucleotide substitution in each base of the sequences was estimated by the Kimura two-parameter method. A phylogenetic tree was constructed by the neighbor-joining method, and its reliability was estimated by 1000 bootstrap replications. The phylogenetic tree was constructed using the MEGA version 4 software package [7] .
Statistical Analysis
All analyses were performed using SPSS version 16 (SPSS, Chicago, IL, USA). Descriptive statistics were generated. For univariate analysis, frequencies and medians of all variables and measures were calculated. Comparisons between groups were performed using the Chi-square tests for proportions and the Student's t-test for proportional and continuous variables.
Results
Out of 148 blood samples, two (1.4%) were resulted HTLV-1/2-positive in screening tests conducted by ELISA HTLV-1/2. Both anti HTLV-1/2 positive samples were from Women Prison Semarang. For the two reactive samples in the serologic screening, it was possible to perform PCR in all cases (100%), of which all samples confirmed the presence of HTLV-DNA in the PBMC for the LTR regions of the genome. Of these, one was HTLV-1 and the other was HTLV-2 positive. Based on 317 nucleotides part of HTLV-1 LTR region, the HTLV-1 isolate (09IDSKAH-1-1, GenBank Accession Number JN247455) was shared 100% homology with B1033-2009 (HTLV-1 isolated in Japan; GenBank Accession Number AB513134) (Fig. 1) . Based on 666 nucleotides part of HTLV-2 LTR region, 09IDSKAH-2-1 (GenBank Accession Number JN247458) had shared 99% homology with HTLV-2 isolated in USA (GenBank Accession Number: AF412314) (Fig. 2) . There no significant difference in socio-demographic characteristics was observed in both correctional facilities. In addition, no relationship with factors associated with HTLV-1/2 infection was detected, except for both individuals with anti HTLV-1/2 positive were reported had piercing and tattooing. The piercing and tattooing were performed in local parlors with a possibility of sharing needles and/ Nucleotide sequences of partial HTLV-2 LTR were aligned using ClustalW. The HTLV-2 isolated in USA (GenBank Accession Number AF412314), Belgium (GenBank Accession Number Y09148), Ireland (GenBank Accession Number AF032992), Brazil (GenBank Accession Number AF401494) and Cameroon (GenBank Accession Number Z46838) were also included in the phylogenetic tree, respectively.
or unsterile needles used since both positive individuals were not sure about the needles condition. Both positive individuals were married with no unmarried sexual activities history. We could not found any significant contribution of socio-demographic characteristics, travel, incarceration and medical histories, drug use and sexual behaviors, especially that of related to risk factors for HTLV-1/2 infection.
Discussion
HTLV-1 and -2 are transmitted in three ways: (1) between sexual partners, mainly from man to woman; (2) through blood transfusion with HTLV-infected cells; and (3) from mother to child during prolonged breastfeeding. In areas where the virus is highly endemic, mother-to-child transmission is sometimes the predominant route. In Japan, an area where HTLV-1 infection is highly endemic, antenatal screening and a recommendation for formula feeding of infants of HTLV-1-seropositive mothers have been instituted successfully since 1987 [8] . Similar recommendations were proposed in Europe and the Caribbean [9] . The seroprevalence varies considerably by sex, age, and region (5% in urban adult's areas, 8.5 to 10.5% in rural adults) [10, 11] . The huge number of HTLV-1-infected men among blood donors could be a consequence of the high number of donors of this gender. An age-and-gender-cohort effect due to the characteristics of blood donors worldwide could not be excluded [12] .
The prevalence of HTLV-1 infection among pregnant women was estimated to be 5.5 to 6.8%. Most previous studies, however, have been carried out in only one region of the country, the southeast, and the results may therefore not reflect the national prevalence, due to possible regional foci, a hallmark of HTLV-1 infection. Furthermore, the reported rate might be under-or rather overestimated, as in most cases HTLV-1 detection by confirmatory testing with strict Western blot criteria and/or PCR was not done.
Since 2009, our group began screening the high risk communities for human blood borne viruses' infection for HIV, hepatitis B, hepatitis C, hepatitis D, Torque Teno Virus, and HTLV-1/2. In our present study, the seroprevalence of HTLV-1/2 was low. A possible explanation for the low prevalence is the improvement of ELISA test quality, with reduction in the number of false positive tests. The low return rate for the confirmatory test demonstrated the need to reevaluate the current methods of dealing with reactive samples. [13] [14] [15] [16] [17] . Regarding the sensitivity and specificity of the HTLV screening kits employed in the present study, all samples positive by ELISA kits were confirmed by PCR, therefore the kits was highly sensitive in detecting HTLV-1 and HTLV-2 antibodies. However, this work was limited by its cross-sectional design, and follow-up of such individuals was not done. Finally, the main result that emerges from this study is the HTLV-1 and HTLV-2 was detected in drug abused prisoners in Indonesia. The possible transmission route(s) on the two positive persons were piercing and or tattooing since both of the positive individuals were not sure about the needles-used condition and no risk factors related to the blood borne virus infection could be found. However, the possibility of other potential transmission routes (e.g., transversal infection and or sexual transmission from their husband) could not be neglected and need further study. The correct diagnosis of HTLV-1/2 is important for prompt attention and counseling these individuals to avoid vertical and sexual virus transmission. Indeed, the results obtained suggest that HTLV-1 and HTLV-2 has probably been introduced in healthy persons in Indonesia.
